Literature DB >> 16621930

Esophageal cancer: evaluation with triple-phase dynamic CT--initial experience.

Shigeaki Umeoka1, Takashi Koyama, Kaori Togashi, Tsuneo Saga, Go Watanabe, Yutaka Shimada, Masayuki Imamura.   

Abstract

PURPOSE: To prospectively assess which phase of a triple-phase dynamic contrast material-enhanced multi-detector row computed tomography (CT) protocol is optimal for visualization of esophageal cancer.
MATERIALS AND METHODS: The study was supported by the local ethical committee; all patients gave written informed consent. Thirty-one lesions in 28 consecutive patients (26 men, two women; mean age, 65 years; range, 53-87 years) with histopathologically confirmed esophageal cancer were evaluated with triple-phase dynamic CT performed at 5, 35, and 65 seconds (first arterial, second arterial, and venous phases) after attenuation of 200 HU was obtained at the descending aorta. Qualitative image analysis was performed to assess appearance and conspicuity of the tumor. Appearances of all 31 lesions were classified into three categories-not identifiable, focal enhancement with or without minimal (<1 cm) wall thickening, and focal mass lesion or obvious (>1 cm) wall thickening. Results were compared with surgical or endoscopic ultrasonographic findings. Quantitative assessment included regions-of-interest measurement of the tumor and normal esophageal wall and the difference between those measurements. A paired t test was used to determine which phase showed the highest tumor attenuation and tumor-to-normal esophageal wall attenuation differences.
RESULTS: At visual assessment, 30 lesions were identified in the second arterial phase. Of these 30 lesions, eight were focal enhancements; the best conspicuity was during the second arterial phase. Furthermore, seven of these eight lesions were T1 cancers. The remaining 22 lesions were enhanced masses or wall thickening. Twenty-one of these 22 tumors also showed best conspicuity in the second arterial phase. The greatest attenuation of tumors in the second arterial phase was 130.0 HU, and the difference in attenuation between tumor and normal esophageal wall was 50.6 HU in the second arterial phase, which were significantly higher than those in the other two phases (P<.01, each).
CONCLUSION: The second arterial phase of dynamic CT is the optimal phase for visualization of esophageal cancer. Copyright (c) RSNA, 2006.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621930     DOI: 10.1148/radiol.2393050222

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  Value of two-phase dynamic multidetector computed tomography in differential diagnosis of post-inflammatory strictures from esophageal cancer.

Authors:  Grigory G Karmazanovsky; Svetlana A Buryakina; Evgeny V Kondratiev; Qin Yang; Dmitry V Ruchkin; Dmitry V Kalinin
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

2.  [Radiological imaging of the upper gastrointestinal tract. Part 1. The esophagus].

Authors:  J Hansmann; L Grenacher
Journal:  Radiologe       Date:  2006-12       Impact factor: 0.635

Review 3.  [MSCT for staging and response evaluation of esophageal cancer].

Authors:  K Holzapfel; E J Rummeny; C Hannig; A J Beer
Journal:  Radiologe       Date:  2007-02       Impact factor: 0.635

Review 4.  Intramural hematoma of the esophagus: a pictorial essay.

Authors:  Carlos S Restrepo; Diego F Lemos; Daniel Ocazionez; Rogelio Moncada; Carlos R Gimenez
Journal:  Emerg Radiol       Date:  2007-10-20

5.  Quantitative measurement of contrast enhancement of esophageal squamous cell carcinoma on clinical MDCT.

Authors:  Rui Li; Tian-Wu Chen; Li-Ying Wang; Li Zhou; Hang Li; Xiao-Li Chen; Chun-Ping Li; Xiao-Ming Zhang; Ru-Hui Xiao
Journal:  World J Radiol       Date:  2012-04-28

6.  Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma.

Authors:  Xianzheng Tan; Zelan Ma; Lifen Yan; Weitao Ye; Zaiyi Liu; Changhong Liang
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

7.  A retrospective analysis of oesophageal thickening diagnosed as an incidental finding at Computed Tomography with endoscopic and histological correlation.

Authors:  U Salati; K Courtney; H K Kok; W Torreggiani
Journal:  Ir J Med Sci       Date:  2014-10-22       Impact factor: 1.568

8.  Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results.

Authors:  Ahmed Ba-Ssalamah; Wolfgang Matzek; Susanne Baroud; Nina Bastati; Johannes Zacherl; Sebastian F Schoppmann; Michael Hejna; Fritz Wrba; Michael Weber; Christian J Herold; Richard M Gore
Journal:  Eur Radiol       Date:  2011-06-28       Impact factor: 5.315

9.  Preoperative assessment of tumor location and station-specific lymph node status in patients with adenocarcinoma of the gastroesophageal junction.

Authors:  Brechtje A Grotenhuis; Bas P L Wijnhoven; Jan Werner Poley; John J Hermans; Katharina Biermann; Manon C W Spaander; Marco J Bruno; Hugo W Tilanus; J Jan B van Lanschot
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

10.  Diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion of gastrointestinal cancers.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Kazunori Fugo; Takafumi Sunaoshi; Daisuke Kano; Satomi Tanaka; Aika Ozaki; Eriko Sugiyama; Misaki Shite; Ryouta Haga; Akira Baba; Yoshiya Fukamizu; Toshiyuki Fujita; Satoshi Kagayama; Rumiko Hasegawa; Akira Togawa; Yoshinori Shirai; Noboru Ichiki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Takashi Kishimoto; Naoki Ishige
Journal:  Mol Clin Oncol       Date:  2016-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.